SVB Leerink raised the price target for the Immunic Inc (NASDAQ:IMUX) stock to “”a Mkt perform””
SVB Leerink raised the price target for the Immunic Inc (NASDAQ:IMUX) stock from “an Outperform” to “a Mkt perform”. The rating was released on October 21, 2022, according to finviz. The research report from Aegis Capital has initiated the stock to Buy, with a price target set at $55. The stock was initiated by JMP […]
Immunic Inc (IMUX) Stock to return to profitability in the near future
SVB Leerink raised the price target for the Immunic Inc (NASDAQ:IMUX) stock from “an Outperform” to “a Mkt perform”. The rating was released on October 21, 2022, according to finviz. The research report from Aegis Capital has initiated the stock to Buy, with a price target set at $55. The stock was initiated by JMP […]
